DALFAMPRIDINE
UNII BH3B64OKL9

Substance Identification & Data

This profile provides standardized clinical and technical data for Dalfampridine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BH3B64OKL9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 504-24-5 and the RxNorm Concept ID (RxCUI) 897018. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

BH3B64OKL9

CAS Registry Number

504-24-5

RxNorm Concept ID

897018

Detailed Substance Profile

Preferred Name

DALFAMPRIDINE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

BH3B64OKL9

The specific atomic composition represented as a molecular structure string.

InChIKey

C5H6N2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

NUKYPUAOHBNCPY-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C76777

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

1727

Unique identification number in the NCBI database of chemical substances.

INN ID

7283

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

FF-74

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1ccc(cc1)N

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dalfampridine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.